Research demonstrates enhanced photodynamic therapy performance in biological media using modified porphyrins, suggesting new therapeutic strategies.
In this work, we explore the use of porphyrin/fluorene assemblies as luminescent photosensitizers (PSs) for two-photon photodynamic therapy in biological media. In this context, we systematically investigated a series of star-shaped hydrophobic porphyrins bearing four arms composed of either a single fluorenyl unit or two fluorenyls linked by triple or double bonds. These fluorenyl-porphyrins, previously identified as efficient fluorescent two-photon PSs in organic solvents, were encapsulated at various loadings in poly(benzyl malate)-based polymeric nanoparticles (NPs). Notably, promising PDT activity was observed in aqueous media for formulations with high PS loading (25 wt %), confirming this encapsulation strategy as an accessible and cost-effective approach for porphyrin biocompatibilization. Despite their strong confinement within the nanoparticles, the encapsulated porphyrins retained significant luminescent properties suitable for bioimaging, supporting the theranostic potential of these nanosystems.
No takes yet. Share an insight, caveat, or question.
Gorbunova et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: